HealthResearch uncovers new mechanism in protein aggregation linked to...

Research uncovers new mechanism in protein aggregation linked to Parkinson’s disease

-

spot_img



A team of researchers at Kumamoto University has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson’s Disease. The team, led by Professor Norifumi Shioda and Associate Professor Yasushi Yabuki, identified for the first time that unique RNA structures called G-quadruplexes (G4s) play a central role in promoting the aggregation of α-synuclein, a protein associated with neurodegeneration. By demonstrating that inhibiting G4 assembly could potentially prevent the onset of synucleinopathies, this discovery positions G4 as a promising target for early intervention in these diseases.

In a healthy state, α-synuclein typically regulates neuronal function. However, in neurodegenerative diseases, it aggregates together, leading to cell damage and motor symptoms. The researchers identified that G4s, four-stranded RNA structures that form in response to cellular stress, function as a “scaffold” that facilitates α-synuclein aggregation. Elevated calcium levels, often seen under stress, trigger G4 assembly, which then attracts α-synuclein, converting it into a harmful, aggregate-prone state.

The team went a step further, demonstrating a new approach to prevent this process. They administered 5-aminolevulinic acid (5-ALA), a compound that blocks G4 formation, to model mice exhibiting Parkinson’s-like symptoms. Impressively, 5-ALA treatment not only prevented α-synuclein aggregation but also halted the progression of motor symptoms, a promising sign for potential therapies targeting early-stage neurodegeneration.

This breakthrough could significantly advance treatments aimed at neurodegenerative diseases by focusing on G4 regulation. Since G4s are also implicated in other diseases such as Alzheimer’s Disease, this discovery may broaden the impact of such treatments beyond Parkinson’s Disease. These findings were published in the journal Cell on October 18, 2024, shedding new light on preemptive strategies to combat neurodegeneration and improve quality of life for aging populations.

Source:

Journal reference:

Matsuo, K., et al. (2024). RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation. Cell. doi.org/10.1016/j.cell.2024.09.037.



Source link

Latest news

Amal Clooney Trades In Her Glamorous Dresses for Off-Duty Athleisure

This month, Amal Clooney and George Clooney have been enjoying a vacation in the south of France (jealous!),...

Trump names Treasury adviser from first term to chair economic panel

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election means for Washington...

24 Best Korean Skin-Care Products, Tested & Reviewed

Key ingredients: yuja, vitamin C, hyaluronic acid | Who it's for: people with dry, dehydrating skin | Fragrance-free:...

15 Best Curly Hair Products 2025 for Every Curl Type and Texture

Key ingredients: meadowfoam seed oil, tsubaki seed oil | Best for: all curl typesBest for Type 2 Curls:...
spot_img

Tottenham v Liverpool: Premier League – live | Premier League

Key eventsShow key events onlyPlease turn on JavaScript to use this featureLiverpool will be top at Christmas regardless...

Urinary tract infections are common in women, say doctors

Urinary tract infection is very common in women, with one in three having an episode before they turn...

Must read

Amal Clooney Trades In Her Glamorous Dresses for Off-Duty Athleisure

This month, Amal Clooney and George Clooney have...

Trump names Treasury adviser from first term to chair economic panel

Unlock the White House Watch newsletter for freeYour...
spot_img

You might also likeRELATED
Recommended to you